Article Details
Retrieved on: 2020-12-05 07:36:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... according to Zacks Investment Research. Two analysts have provided estimates for Mersana Therapeutics' earnings, with the lowest EPS estimate ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here